Empagliflozin in Heart Failure with a Preserved Ejection FractionStefan D. Anker, Milton Packer, Javed Butler et al.|New England Journal of Medicine|2021Cited by 4.6k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus PanelBrian A. Ference, Alberico L. Catapano, Henry N. Ginsberg et al.|European Heart Journal|2017Cited by 3.8k
Effect of Very High-Intensity Statin Therapy on Regression of Coronary AtherosclerosisSteven E. Nissen, for the ASTEROID Investigators, Stephen J. Nicholls et al.|JAMA|2006Cited by 2k
Effects of Dalcetrapib in Patients with a Recent Acute Coronary SyndromeGregory G. Schwartz, R. Scott Wright, John J.V. McMurray et al.|New England Journal of Medicine|2012Cited by 2k
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus PanelJan Borén, Henry N. Ginsberg, M. John Chapman et al.|European Heart Journal|2020Cited by 1.5k